Clinicopathologic Features and Radiation Therapy Utilization in Patients with Male Breast Cancer: A National Cancer Database Study
Male breast cancer (MBC) accounts for approximately 1% of all breast cancers, limiting the data characterizing clinicopathologic features and treatment outcomes in patients with MBC. This paucity of data has led to most of our treatment guidance being extrapolated from patients with female breast ca...
Main Authors: | Joshua Weir, Yan Daniel Zhao, Terence Herman, Özer Algan |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-04-01
|
Series: | Breast Cancer: Basic and Clinical Research |
Online Access: | https://doi.org/10.1177/1178223418770687 |
Similar Items
-
Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database
by: Shuting Li, et al.
Published: (2019-11-01) -
Male Breast Cancer: Clinicopathological, Immunohistochemical and Radiological Study
by: Bermal HASBAY, et al.
Published: (2020-09-01) -
Male Breast Cancer in Togo: Imaging and Clinicopathological Findings
by: Tchin Darre, et al.
Published: (2020-01-01) -
Male Breast Cancer: A Comparative Analysis from the National Cancer Database
by: Elizabeth B. Elimimian, et al.
Published: (2021-07-01) -
Clinicopathological Features of Young Versus Older Patients With Breast Cancer at a Single Pakistani Institution and a Comparison With a National US Database
by: Sana Zeeshan, et al.
Published: (2019-03-01)